Advertisement

Ads Placeholder
Loading...

Scholar Rock Holding Corporation

SRRK•NASDAQ
Healthcare
Biotechnology
$50.01
$0.66(1.34%)
U.S. Market opens in 27h 43m

Scholar Rock Holding Corporation (SRRK) Stock Overview

Explore Scholar Rock Holding Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.7B
P/E Ratio-15.18
EPS (TTM)$-3.29
ROE-1.46%
Fundamental Analysis

AI Price Forecasts

1 Month$34.44
3 Months$33.48
1 Year Target$60.19

SRRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scholar Rock Holding Corporation (SRRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $60.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.18 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.34%
5-Day Change
13.30%
1-Month Change
12.86%
3-Month Change
16.85%
6-Month Change
33.47%
Year-to-Date (YTD) Change
16.85%
1-Year Change
62.90%
3-Year Change
492.54%
5-Year Change
10.81%
All-Time (Max) Change
222.65%

Contact Information

https://scholarrock.com
857 259 3860
301 Binney Street, Cambridge, MA, 02142

Company Facts

1,280 Employees
IPO DateMay 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions